Bruce Ruben, MD
Infectious Disease · West Bloomfield, MINPI 1740376714
Payments from drug & device makers
Across 52 payments — averaging $21.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Paratek Pharmaceuticals, Inc.$171
- AbbVie$141
- Melinta Therapeutics, LLC$121
- Integra Lifesciences Corporation$117
- Merck$96
- Tetraphase Pharmaceuticals, Inc.$70
- plus $376 from 12 others
What the payments were for
- Food & beverage$1,08099%
- Education$121%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Paratek Pharmaceuticals, Inc. | 10 | $171 |
| AbbVie(2 entities) | 7 | $141 |
| Melinta Therapeutics, LLC | 6 | $121 |
| Integra Lifesciences Corporation | 5 | $117 |
| Merck | 6 | $96 |
| Tetraphase Pharmaceuticals, Inc. | 1 | $70 |
| Smith+Nephew | 3 | $70 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $66 |
| Convatec Inc. | 2 | $51 |
| La Jolla Pharmaceutical Company | 2 | $30 |
| Axsome Therapeutics, Inc. | 1 | $29 |
| Angiodynamics, Inc. | 1 | $26 |
| Shionogi Inc | 1 | $25 |
| Aimmune Therapeutics, Inc. | 1 | $25 |
| Invivyd Inc | 1 | $20 |
| Hydrofera LLC | 1 | $12 |
| Mayne Pharma Commercial LLC | 1 | $11 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $9 |
How this compares
$1,092 in reported general payments places this provider in the 70th percentile of 257 infectious disease providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Amoxicillin | 14 | $262 |
Paid to pharmacies, not to this prescriber.
Other infectious disease in West Bloomfield
- Christopher RossWest Bloomfield$4K
- Marcus ZervosDetroit$23.5M
- Louis SaravolatzGrosse Pointe Woods$2.6M
- Smitha GudipatiDetroit$1.9M
- Indira BrarDetroit$1.7M
- Mayur RameshDetroit$1.7M
- Matthew SimsRoyal Oak$1.1M
- Daniel KaulAnn Arbor$1M
- Christopher CarpenterRoyal Oak$1M
- George AlangadenDetroit$987K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.